Skip to main content
. 2022 Mar 2;57(4):246–266. doi: 10.1007/s00535-022-01862-y

Table 4.

Number and frequency of EIs in recent clinical trials for CD (N = 85, including duplicates)

Survey period Endoscopic index Validation Number (%)
2009–2012 (N = 22, including duplicates)
Crohnʼs Disease Endoscopic Index of Severity (CDEIS) Validated 10 (45.5)
Rutgeerts Score Validated 6 (27.3)
Capsule Endoscopy Crohnʼs Disease Activity Index (CECDAI) Validated 3 (13.6)
Simple Endoscopic Score for Crohnʼs Disease (SES-CD) Validated 2 (9.1)
Others (Including original indices for the trial) Not available 5 (7.0)
2013–2017 (N = 63, including duplicates)
Simple Endoscopic Score for Crohnʼs Disease (SES-CD) Validated 31 (49.2)
Rutgeerts Score Validated 23 (36.5)
Crohnʼs Disease Endoscopic Index of Severity (CDEIS) Validated 19 (30.2)
Lewis Score (Capsule Endoscopy Score) Validated 2 (3.2)
Capsule Endoscopy Crohnʼs Disease Activity Index (CECDAI) Validated 1 (1.6)
Others (Including original indices for the trial) Not available 2 (3.2)
2009 to 2017 (N = 85, including duplicates)
Simple Endoscopic Score for Crohnʼs Disease (SES-CD) Validated 33 (38.8)
Crohnʼs Disease Endoscopic Index of Severity (CDEIS) Validated 29 (34.1)
Rutgeerts Score Validated 29 (34.1)
Capsule Endoscopy Crohnʼs Disease Activity Index (CECDAI) Validated 4 (4.7)
Lewis Score (Capsule Endoscopy Score) Validated 2 (2.4)
Others (Including original indices for the trial) Not available 4 (4.7)

EIs endoscopic indices, CD Crohn’s disease